Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broijl, Annemiek, Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results, «EJHAEM», 2023, 4, pp. 1117 - 1131 [articolo]Open Access
Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta, European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours, «THE LANCET. HAEMATOLOGY», 2023, 10, pp. 367 - 381 [articolo]
Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S.; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C., High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 23, pp. 5227 - 5239 [articolo]Open Access
Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C., Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial, «ECLINICALMEDICINE», 2023, 60, Article number: 102017, pp. 1 - 13 [articolo]Open Access
Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tacchetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M., Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1208741, pp. 1 - 12 [articolo]Open Access
Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Alessandro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia, Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature, «MICROORGANISMS», 2023, 11, Article number: 2699, pp. 1 - 12 [articolo]Open Access
Morvan L.; Nanni C.; Michaud A.-V.; Jamet B.; Bailly C.; Bodet-Milin C.; Chauvie S.; Touzeau C.; Moreau P.; Zamagni E.; Kraeber-Bodere F.; Carlier T.; Mateus D., Multiple Myeloma Prognosis From PET Images: Deep Survival Losses and Contrastive Pretraining, «IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES», 2023, 7, pp. 732 - 741 [articolo]
Kraeber-Bodere F.; Jamet B.; Bezzi D.; Zamagni E.; Moreau P.; Nanni C., New Developments in Myeloma Treatment and Response Assessment, «THE JOURNAL OF NUCLEAR MEDICINE», 2023, 64, pp. 1331 - 1343 [articolo]Open Access
Giovannamaria Petrocelli, Provvidenza Maria Abruzzo, Luca Pampanella, Riccardo Tassinari, Serena Marini, Martina Fazzina, Elena Zamagni, Carlo Ventura, Federica Facchin, Silvia Canaider, Oxytocin modulates osteogenic commitment in human adipose-derived mesenchymal stem cells, in: Abstract Book, 2023, pp. 165 - 166 (atti di: Second International StemNet meeting, Brescia, 18 - 19 - 20 ottobre 2023) [atti di convegno-abstract]
Petrocelli, Giovannamaria; Abruzzo, Provvidenza Maria; Pampanella, Luca; Tassinari, Riccardo; Marini, Serena; Zamagni, Elena; Ventura, Carlo; Facchin, Federica; Canaider, Silvia, Oxytocin Modulates Osteogenic Commitment in Human Adipose-Derived Stem Cells, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 10813, pp. 1 - 25 [articolo]Open Access
Annamaria Brioli; Laura Gengenbach; Katia Mancuso; Mascha Binder; Thomas Ernst; Florian H. Heidel; Thomas Stauch; Elena Zamagni; Inken Hilgendorf; Andreas Hochhaus; Monika Engelhardt; Marie von Lilienfeld-Toal, Pomalidomide combinations are a safe and effective option after daratumumab failure, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2023, 149, pp. 6569 - 6574 [articolo]Open Access
Oliva S.; Genuardi E.; Paris L.; D'Agostino M.; Rogers J.; Rota-Scalabrini D.; Jacob A.P.; Patriarca F.; Luppi M.; Bertazzoni P.; Velluti C.; Capra A.; Saraci E.; Rossi M.; Allegra A.; Mina R.; Gentile M.; Kirsch I.R.; Belotti A.; Cavo M.; Bruno B.; Musto P.; Boccadoro M.; Zamagni E.; Gay F., Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing, «ECLINICALMEDICINE», 2023, 60, Article number: 102016, pp. 1 - 12 [articolo]Open Access
Kastritis E.; Terpos E.; Symeonidis A.; Labropoulou V.; Delimpasi S.; Mancuso K.; Zamagni E.; Katodritou E.; Rivolti E.; Kyrtsonis M.-C.; Roussou M.; Fotiou D.; Theodorakakou F.; Ntanasis-Stathopoulos I.; Hatjiharissi E.; Kanellias N.; Migkou M.; Cheliotis G.; Manousou K.; Gavriatopoulou M.; Dimopoulos M.A., Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study, «AMERICAN JOURNAL OF HEMATOLOGY», 2023, 98, pp. E226 - E229 [articolo]
Lehne M.; Kortum K.M.; Ramasamy K.; Zamagni E.; d'Estrube T.; Zhuleku E.; Hanna M.; Shukla S.; Ghiani M.; Maywald U.; Wilke T.; Kellermann L.; Perera S., Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2023, 0, pp. 1 - 1 [articolo]Open Access
Andrea Poletti, Stafano Delle Vedove, Gaia Mazzocchetti, Vincenza Solli, Ajsi Kanapari, Enrica Borsi, Marina Martello, Giovanni Martinelli, Silvia Armuzzi, Ilaria Vigliotta, Barbara Taurisano, Ignazia Pistis, Elena Zamagni, Michele Cavo, Carolina Terragna, A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies, in: Blood (2022) 140 (Supplement 1): 1559–1560., 2022, pp. 1559 - 1560 (atti di: American Society of Hematology, New Orleans, Lousiana, 10-13 December 2022) [Contributo in Atti di convegno]
